Siegfried Kasper

University of Iowa — United States

Medicine · Health Sciences

114h-index54.3kcitations2.1kworks3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Treatment of Major Depression(498), Schizophrenia research and treatment(225), Tryptophan and brain disorders(223), Bipolar Disorder and Treatment(219), Functional Brain Connectivity Studies(202)

Publications2.1k total

( <i>S</i> )-ketamine augments behavioral and physiological responses to Δ <sup>9</sup> -tetrahydrocannabinol
2025
In memoriam: Professor Dan J. Stein (1962-2025) — a global pioneer with an African heart
The International Journal of Neuropsychopharmacology·2025Open Access
Hindrance to precision psychiatry: more sex-specific investigations needed
The World Journal of Biological Psychiatry·2025
Oral ketamine for the treatment of major depressive and bipolar disorder, a randomized controlled trial and meta-analysis
Journal of Affective Disorders·2025Open Access
Human in vivo assessment of ketamine binding of the serotonin transporter—follow up at a higher dose
Frontiers in Neuroscience·2025Open Access
Siegfried Kasper: The importance of back-translation of clinical findings to basic science
Brain medicine :·2025Open Access
Analysis of menstrual effluent uncovers endometriosis-specific cell populations and impaired cellular pathway processes
2025· 1 citedOpen Access
Switching Antipsychotic Drugs: A Pharmacokinetic, Pharmacodynamic, and Practical Perspective
Psychopharmacology Bulletin·2025
Overview of the Safety of Citalopram
Psychopharmacology Bulletin·2025· 19 cited
Clinical predictors of treatment resistant depression
European Neuropsychopharmacology·2025· 8 citedOpen Access
Stathmin Serine 16 Phosphorylation Is a Key Regulator of Cell Cycle Progression Without Activating Migration and Invasion In Vitro
Cancers·2025Open Access
The impact of depression on functioning: Relation to medication response and other predictors
Psychiatry Research·2025· 1 citedOpen Access
In vivo serotonin 1A receptor distribution in treatment-resistant depression
Translational Psychiatry·2025· 2 citedOpen Access
Stathmin Serine 16 Phosphorylation Is a Key Regulator of Cell Cycle Progression Without Activating Metastatic Behavior
Preprints.org·2025Open Access
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis
European Neuropsychopharmacology·2025· 2 citedOpen Access
Correction: Mild motor signs and depression: more than just medication side effects?
European Archives of Psychiatry and Clinical Neuroscience·2025Open Access
Mild motor signs and depression: more than just medication side effects?
European Archives of Psychiatry and Clinical Neuroscience·2025· 1 citedOpen Access
Oral Ketamine for the Treatment of Depression: A randomized controlled trial and meta-analysis
2025· 1 citedOpen Access
Are side effects necessary for antidepressant treatment?
European Psychiatry·2025Open Access
Implementation of the American- College of Physicians Guideline for Low Back Pain (IMPACt-LBP): protocol for a healthcare systems embedded multisite pragmatic cluster-randomised trial
BMJ Open·2025Open Access
page 1 of 104Next →

Frequent Co-authors

Eduard Vieta(10), Rupert Lanzenberger(9), Heinz Grunze(8), Guy M. Goodwin(6), Allan H. Young(6), Charles L. Bowden(6), Rasmus Wentzer Licht(5), Hans‐Jürgen Möller(4), Michael Berk(3), Konstantinos Ν. Fountoulakis(3), Lakshmi N. Yatham(3), Carlos A. Zarate(3), Norman E. Rosenthal(3), Gerard Sanacora(3), Philip Gorwood(3), Stuart Montgomery(3), Hans‐Jürgen Möller(3), Koen Demyttenaere(3), R. Hamish McAllister‐Williams(3), Matthäus Willeit(3)